Top 5 Art VC Funds &amp; Investors in Czech Republic (May 2026)

Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures, has more recently expanded its mission to include a range of innovative investment vehicles to meet the needs of major pharmaceutical companies as well as sophisticated private and institutional investors fromaround the world.Founded in 1999 with its home office in London, Phase4 has invested over $400 million in 24 companies in both Europe and the US, including such notable successes as Pharmion, Arakis, Proteolix, Albireo, and OncoMed (NASDAQ: OMED). Phase4 is particularly proud of its key role in funding the development of breakthrough products such as Kyprolis (acquired by Onyx when it purchased Proteolix); Ultibro Breezhaler (a Novartis product originally developed by Arakis); and Vidaza and Thalomid (both acquired by Celgene when it purchased Pharmion); as well as important advances now in clinical trials including OncoMed’s line of innovative products directed at blocking cancer stem cells and Albireo’s elobixibat, now in Phase III studies being conducted by Albireo’s partner Ferring. All of these products offer significant improvements in the treatment of serious diseases while having the potential to generate large profits for the companies involved as well as our investors.Phase4 is a member of the British Private Equity and Venture Capital Association (BVCA), and the European Private Equity and Venture Capital Association (EVCA).

Investment focus

Industry: Art, Apps, Medical
Stage:Seed, Series B
Geography: Austria, Czech Republic

Investor stats

Total investments: 2
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Avocode — Centralize design collaboration, developer hand-off, version control, screen flows, & feedback in one tool. Sign up free today. Work with Sketch, Adobe XD, Photoshop, Illustrator, and Figma designs on macOS, Windows, and Linux.
Nabriva Therapeutics — Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.

Show all investments...

Kima Ventures is one of the world's most active early-stage investors, investing in 2 to 3 startups per week all over the world; providing founders with funding, network, and support for them to reach the next steps of their journey.The firm invests from seed to Series A, mostly as lead investor but also working alongside other investors;backing ambitious founders who work hard to build awesome things that more and more people use everyday. The company helps them to build a great team, to learn very quickly, to keep the right focus and execute towards growth.Kima takes pride of itself in working side-by-side with entrepreneurs. They claim to understand that fundraising is only one step in the company’s journey, that’s why they take quick decisions and make the fundraising process as smooth as possible so the founders can get back to the work of building their business. Kima considers itself not only an investor, but a network of founders and experts sharing a pay it forward mindset.Headquartered in Paris with an office in London, the company was founded and backed by Xavier Niel, founder of Iliad and supporter of entrepreneurs through such projects as 42, Station F and 101projets. Over the last 5 years Kima has invested in over 400 startups in 24 different countries.

Investment focus

Industry: Software, E-Commerce, SaaS
Stage:Seed, Pre-Seed, Series A
Geography: France, United States, United Kingdom

Investor stats

Total investments: 380
Round size: Seed $250k–$3.5M; Pre-Seed $500k–$3M; Series A $800k–$12M
Lead/follow: 9% lead, 91% follow

Portfolio highlights

Mimbi — Mimbi provides brands and agencies with a platform that allows them to better measure & optimize the impact of retail media campaigns
OnlyDust — OnlyDust is a contribute to the best StarkNet projects, and get paid in USDC or Tokens.
Depot — The fastest place to build Docker images.

Show all investments...

Wisemont Capital fund makes equity investments in early-stage technology companies with a primary focus on wireless and mobility, software, and technology-enabled service companies.Their team of experienced investment professionals is committed to working with entrepreneurs to build great companies that address unmet needs in the marketplace. Inaddition to providing capital, They leverage Their broad industry knowledge, relationships and investment experience to complement the strengths of the entrepreneur. Their focus is on ambitious entrepreneurs, disruptive technology and sustainable businesses.

Investment focus

Industry: Software, Information Technology, Artificial Intelligence
Stage:Seed, Series A, Pre-Seed
Geography: United States, China, India

Investor stats

Total investments: 49
Round size: Seed $317k–$5M; Series A $7M–$8M
Lead/follow: 0% lead, 100% follow
Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

Chirp — Chirp is a social podcast platform that enables users to share their voices in an easy and genuine way. The platform offers to record, edit, add and transform audio and music into a video or podcast that are shared globally, enabling people to tell stories, express opinions, and exchange ideas in an audio format.
CloudVector — CloudVector protects an organization’s internally-developed APIs, third-party application APIs, and the data carried within them. CloudVector provides deep visibility, beyond just the endpoints, into the data transmitted within each API. This unparalleled level of data visibility allows CloudVector to protect your organization’sinternally-developed APIs, third-party application APIs, and the data carried within them.
iLabService — ILabService simplifies lab operation by using IoT and AI technologies. The company provides subscription monitoring services for lab equipment in biotechnology and pharmaceutical labs. Their software and easy-to-install sensors ensure each piece of equipment is operating according to their specifications, alerting technicians when there areproblems.

Show all investments...

Doing business may resemble a jungle survival. You better be prepared and have the right reflexes! It's also useful to have someone with real experience around. We at Reflex Capital are entrepreneurs, just like you. We built our own companies, negotiated with investors, and took part in plenty of transactions.

Investment focus

Industry: Software, SaaS, Information Technology
Stage:Seed, Series A, Pre-Seed
Geography: Czech Republic, United States, United Kingdom

Investor stats

Total investments: 56
Round size: Seed $200k–$2.3M; Pre-Seed $750k–$1.2M; Series A $1.3M–$3.5M
Lead/follow: 32% lead, 68% follow
Last fund: May invest from a new fund soon — raised $11M in 2016

Portfolio highlights

Fitify — Your personal workout app. Workout routines & training plan at home.
VOS.health (AI Mental Health App) — Boost mental health and wellbeing with VOS.health. Conquer stress, anxiety, and depression while enhancing productivity through personalized plans and mood tracking. Join VOS, a community that understands and supports your journey.
Flow Nutrition — Flow develops products for the proper functioning of the body in the demanding conditions of the 21st century

Show all investments...